Diffuse Large B Cell Lymphoma CD20+

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00290Bleomycin3Terminated1
DB00531Cyclophosphamide3Terminated1
DB00997Doxorubicin3Terminated1
DB08935Obinutuzumab3Terminated1
DB00635Prednisone3Terminated1
DB00073Rituximab3Terminated1
DB00541Vincristine3Terminated1